Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Supportive regulatory framework and rising emphasis on patient safety
3.2.1.2 Growing pharmaceutical and biotechnology industry
3.2.1.3 Widespread adoption of single-use technology
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of testing
3.2.2.2 Complexity associated with extractable and leachable testing
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Container closure systems
5.3 Single-use systems
5.4 Drug delivery systems
5.5 Other product types
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Parenteral drug products
6.3 Orally inhaled and nasal drug products (OINDPs)
6.4 Ophthalmic drug products
Chapter 7 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Argentina
7.5.3 Mexico
7.5.4 Rest of Latin America
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 BA Sciences
8.2 Eurofins Scientific
8.3 Intertek Group plc
8.4 Limerston Capital LLP
8.5 Merck & Co., Inc.
8.6 Pacific Biolabs, Inc.
8.7 SGS Societe Generale de Surveillance SA
8.8 Sotera Health Co
8.9 West Pharmaceutical Services, Inc.
8.10 WuXi AppTec Co., Ltd.
